Drug Type Small molecule drug |
Synonyms (+)-(S)-p-isobutylhydratropic acid, (2S)-2-(4-isobutylphenyl)propanoic acid, (S)-α-methyl-4-(2-methylpropyl)benzeneacetic acid + [19] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date Austria (27 Jul 2000), |
RegulationPriority Review (China) |
Molecular FormulaC13H18O2 |
InChIKeyHEFNNWSXXWATRW-JTQLQIEISA-N |
CAS Registry51146-56-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03715 | Dexibuprofen |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Inflammation | South Korea | 31 Dec 2007 | |
Fever | China | 01 Jan 2001 | |
Osteoarthritis | China | - | 01 Jan 2001 |
Rheumatoid Arthritis | China | - | 01 Jan 2001 |
Pain | Austria | 27 Jul 2000 | |
Pain | Italy | 27 Jul 2000 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Analgesia | Phase 2 | China | 13 Jul 2021 | |
Analgesia | Phase 2 | China | 13 Jul 2021 | |
Anesthesia | Phase 2 | China | 16 Nov 2020 | |
Anesthesia | Phase 2 | China | 16 Nov 2020 | |
Acute Pain | Phase 2 | United States | 12 Jan 2018 | |
Myalgia | Phase 2 | United States | 01 Jan 2015 | |
Dysmenorrhea | Phase 1 | China | 17 May 2023 |
Phase 2 | 251 | (Active Arm) | wvxzstdbkk(cguucgqaxr) = hsikfzxuxf zhzgazvauw (sxsvdrifxa, 31.311) View more | - | 25 Jan 2022 | ||
Vehicle (Placebo Arm) | wvxzstdbkk(cguucgqaxr) = hdzcdezmbn zhzgazvauw (sxsvdrifxa, 29.763) View more | ||||||
Phase 3 | 263 | czkrcyppvd(nydpcmphra) = nxtwzhtvps wmzdkwioop (fuonpaaqoq ) | - | 23 Jun 2018 | |||
czkrcyppvd(nydpcmphra) = zwszhookgr wmzdkwioop (fuonpaaqoq ) |